UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of February 2026
Commission file number: 001-39738
Ucommune International Ltd
No. 2 Dongsihuan North Road, Building 1, 4th Floor
Chaoyang District, Beijing 100016
People’s Republic of... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 9, 2026
(Exact name of Registrant as Specified in Its Charter)
Delaware ... (continue reading...)
More SEC Filings
View Older Stories-
Form 13F-HR HS Management Partners, For: Dec 31
-
Form 8-K Ouster, Inc. For: Feb 09
-
Form 6-K Kanzhun Ltd For: Feb 09
-
Form 6-K ANDINA BOTTLING CO INC For: Feb 09
-
Form 15-12G Venus Concept Inc.
-
Form 4 REGIONAL HEALTH PROPERTI For: Jan 16 Filed by: MARTIN STEVEN L
-
Form 4 REGIONAL HEALTH PROPERTI For: Jan 16 Filed by: BAILEYS STEVEN J
-
Form 8-K Kyndryl Holdings, Inc. For: Feb 09
-
Form 6-K Brera Holdings PLC For: Feb 09
-
Form 4 REGIONAL HEALTH PROPERTI For: Jan 16 Filed by: Taylor Kenneth Wayne
-
Form 6-K Can-Fite BioPharma Ltd. For: Feb 09
-
Form 10-Q HAIN CELESTIAL GROUP For: Dec 31
-
Form 4 REGIONAL HEALTH PROPERTI For: Jan 16 Filed by: BURLESON GENE E
-
Form 4 REGIONAL HEALTH PROPERTI For: Jan 16 Filed by: KELLMAN F SCOTT
-
Form 4 REGIONAL HEALTH PROPERTI For: Jan 16 Filed by: WINKLE C CHRISTIAN
-
Form 8-K HAIN CELESTIAL GROUP For: Feb 09
-
Form D KA-0119 Fund I, a series
-
Form 6-K Pulsenmore Ltd. For: Feb 09
-
Form D VA-1218 Fund II, a serie
-
Form 8-K Advantage Solutions Inc. For: Feb 06
-
Form DEFA14A ANALOG DEVICES INC
-
Form 6-K Zhihu Inc. For: Feb 09
-
Form 8-K FIRST BANCORP /PR/ For: Feb 04
-
Form 8-K Outdoor Holding Co For: Feb 09
-
Form SCHEDULE 13G/A NOVA LTD. Filed by: Harel Insurance Investments & Financial Services Ltd.
-
Form 8-K Lifeward Ltd. For: Feb 03
-
Form 8-K WATERS CORP /DE/ For: Feb 09
-
Form 6-K NICE Ltd. For: Feb 09
-
Form 8-K WESTERN DIGITAL CORP For: Feb 05
-
Form 6-K monday.com Ltd. For: Feb 09
-
Form 425 WEBSTER FINANCIAL CORP Filed by: Banco Santander, S.A.
-
Form 6-K Osisko Development Corp. For: Feb 09
-
Form 6-K JBS N.V. For: Feb 08
-
Form 8-K Pagaya Technologies Ltd. For: Feb 09
-
Form 6-K YXT.COM GROUP HOLDING For: Feb 09
-
Form 13F-HR Lind Value II ApS For: Dec 31
-
Form S-3ASR AMC ENTERTAINMENT HOLDIN
-
Form 13F-HR Life Cycle Investment For: Dec 31
-
Form 8-K Kyndryl Holdings, Inc. For: Feb 05
-
Form SCHEDULE 13G Kura Oncology, Inc. Filed by: STATE STREET CORP
-
Form SCHEDULE 13G KROGER CO Filed by: STATE STREET CORP
-
Form 6-K Reitar Logtech Holdings For: Feb 09
-
Form SCHEDULE 13G KRATOS DEFENSE & SECURIT Filed by: STATE STREET CORP
-
Form 8-K Sally Beauty Holdings, For: Feb 09
-
Form SCHEDULE 13G KOPIN CORP Filed by: STATE STREET CORP
-
Form NT 10-Q Kyndryl Holdings, Inc. For: Dec 31
-
Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: STATE STREET CORP
-
Form SCHEDULE 13G IOVANCE BIOTHERAPEUTICS, Filed by: STATE STREET CORP
-
Form 6-K Inspira Technologies For: Feb 09
-
Form SCHEDULE 13G Intellia Therapeutics, Filed by: STATE STREET CORP

